Jeffrey Goldstein
Papers
1
Total Citations
8
H-Index
1
About
Dr. Jeffrey Goldstein is a leading surgical oncologist whose research focuses on optimizing outcomes in head and neck cancer surgery, particularly for human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma. His major contributions center on improving surgical precision through intraoperative margin assessment during transoral robotic surgery (TORS). In his highly cited 2022 study, Dr. Goldstein demonstrated that the use of intraoperative frozen section controls significantly enhances margin assessment, addressing the critical challenge of tissue artifact that can compromise pathologic certainty in TORS procedures. This work has direct implications for ensuring complete tumor resection while preserving healthy tissue, a balance vital for patient prognosis and quality of life. With 8 citations, his research is gaining recognition among surgeons and pathologists seeking to refine robotic surgical techniques. Dr. Goldstein’s achievements underscore his commitment to advancing minimally invasive approaches that improve oncologic outcomes, making him a notable figure in the evolving landscape of HPV-related oropharyngeal cancer management.
Research Focus
Key Achievements
Top Papers
- 1